data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Orchard Therapeutics
(NASDAQ:ORTX)
0.55
-0.0668[-10.83%]
At close: Jun 24
0.541
-0.0090[-1.64%]
After Hours: 7:59PM EDT
Day High/Low0.55 - 0.64
52 Week High/Low0.41 - 5.02
Open / Close0.63 / 0.55
Float / Outstanding- / 125.9M
Vol / Avg.1.3M / 681K
Mkt Cap69.2M
P/E-
50d Avg. Price0.53
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float117.3M

Orchard Therapeutics (NASDAQ:ORTX), Quotes and News Summary

Orchard Therapeutics (NASDAQ: ORTX)

Day High/Low0.55 - 0.64
52 Week High/Low0.41 - 5.02
Open / Close0.63 / 0.55
Float / Outstanding- / 125.9M
Vol / Avg.1.3M / 681K
Mkt Cap69.2M
P/E-
50d Avg. Price0.53
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float117.3M
Benzinga - May 13, 2022, 7:42AM
Benzinga - May 12, 2022, 7:25AM
Benzinga - Apr 11, 2022, 7:20AM
Benzinga - Apr 8, 2022, 4:22PM
Benzinga - Apr 6, 2022, 10:10AM
Benzinga - Apr 1, 2022, 9:38AM
Benzinga - Mar 31, 2022, 4:40AM
Benzinga - Mar 30, 2022, 12:02PM
Benzinga - Mar 30, 2022, 7:08AM
Benzinga - Jan 21, 2022, 7:02AM
Benzinga - Dec 16, 2021, 10:21AM
Benzinga - Nov 16, 2021, 5:24AM
load more
Sector: Health Care.Industry: Biotechnology
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.260-0.350 -0.0900
REV3.960M5.524M1.564M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Orchard Therapeutics Questions & Answers

Q
How do I buy Orchard Therapeutics (ORTX) stock?
A

You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Orchard Therapeutics's (ORTX) competitors?
Q
What is the target price for Orchard Therapeutics (ORTX) stock?
A

The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by Barclays on Friday, May 13, 2022. The analyst firm set a price target for 4.00 expecting ORTX to rise to within 12 months (a possible 627.27% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Orchard Therapeutics (ORTX)?
A

The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $0.55 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Orchard Therapeutics (ORTX) pay a dividend?
A

There are no upcoming dividends for Orchard Therapeutics.

Q
When is Orchard Therapeutics (NASDAQ:ORTX) reporting earnings?
A

Orchard Therapeutics’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Orchard Therapeutics (ORTX) going to split?
A

There is no upcoming split for Orchard Therapeutics.

Q
What sector and industry does Orchard Therapeutics (ORTX) operate in?
A

Orchard Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.